News
Lilly confirmed it would buy a Boston-based clinical-stage company developing genetic medicines for cardiovascular disease.
Investors look to gauge the size of the chip maker’s opportunity in artificial intelligence. One Wall Street analyst argues ...
Exelon is a top choice for conservative investors with a strong dividend, growth potential, and resilience to rising ...
ReNew Energy Global harnesses India's solar boom with a clean-energy platform, showing strong growth, battery storage launch.
Right now, Chevron ( CVX 0.14%) is one high-yield energy laggard that is worth buying and holding for the long term. The ...
Regardless of which you choose, Pfizer's (NYSE: PFE) share price has declined during the period. Pfizer's dismal stock ...
Explore more
Verve Therapeutics’ stock rallies by a record 80% on Eli Lilly’s premium purchase price for the drug-development company.
Does the mail run on Juneteenth 2025? Are banks open? Is the stock market open? Is the MVC open? What is NJ Transit's ...
Promoter Vedanta is likely to sell Hindustan Zinc's shares worth up to Rs 7,500 crore through block deals on June 18, ...
In a circular, the NSE announced that SEBI has approved its proposal to shift the expiry day of derivatives contracts to ...
Nixing federal income taxes on overtime and tipped income was one of the president's top policy promises during his 2024 ...
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial” or the "Company”), a clinical-stage biopharmaceutical company focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results